"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal

Affiliations

• ¹ 4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Attikon University General Hospital of Athens, Athens, Greece. gpoulakou@gmail.com.
• ² Department of Critical Care, University Hospital Attikon, Medical School, University of Athens, Athens, Greece.
• ³ Infectious Diseases Division, Azienda Ospedaliera Universitaria Santa Maria Misericordia Hospital, Udine, Italy.
• ⁴ Principal Coordinator, ID-IRI, Ankara, Turkey.
• ⁵ Infectious Diseases Department, Buenos Aires University, Buenos Aires, Argentina.
• ⁶ , 9 rue de la Terrasse, 94000, Creteil, France.
• ⁷ Intensive Care Services, Royal Brisbane and Women's Hospital, Herston, Brisbane, QLD, 4029, Australia.
• ⁸ Anaesthesiology and Critical Care, School of Medicine, The University of Queensland, Brisbane, Australia.
• ⁹ Faculty of Health, Queensland University of Technology, Brisbane, Australia.
• ¹⁰ The George Institute for Global Health, University of Sydney, Sydney, Australia.
• ¹¹ University of Witwatersrand, Johannesburg, South Africa.
• ¹² Université Paris Diderot/Hopital Bichat-Réanimation Medicale et Des Maladies Infectieuses, 46 rue Henri Huchard, 75018, Paris, France.
• ¹³ UMR 1137-IAME Team 5-DeSCID: Decision SCiences in Infectious Diseases, Control and Care, Inserm/Univ Paris Diderot, Sorbonne Paris Cité, 75018, Paris, France.
• ¹⁴ 6th Department of Internal Medicine, Hygeia Hospital, Marousi, Athens, Greece.
• ¹⁵ National and Kapodistrian University of Athens, Medical School, Attikon University General Hospital of Athens, Athens, Greece.
• ¹⁶ CIBERES, Universitat Autonoma de Barcelona, Barcelona, Spain.